RocketFuel Blockchain (RKFL) 10-Q 22 Feb 22 2021 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Dec. 31, 2021	Feb. 22, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2021
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--03-31
Entity File Number	033-17773-NY
Entity Registrant Name	ROCKETFUEL BLOCKCHAIN, INC.
Entity Central Index Key	0000823546
Entity Tax Identification Number	90-1188745
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	201 Spear Street
Entity Address, Address Line Two	Suite 1100
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94105
City Area Code	(424)
Local Phone Number	256-8560
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		31,975,083

Balance Sheets (Unaudited)

Balance Sheets (Unaudited) - USD ($)	Dec. 31, 2021	Mar. 31, 2021
Current Assets:
Cash	$ 3,504,914	$ 800,331
Accounts receivable	16,325	10,000
Prepaid and other current assets	57,338	5,000
Total current assets	3,578,577	815,331
Total Assets	3,578,577	815,331
Current liabilities:
Accounts payable and accrued expenses	137,683	144,830
Payable to related party	22,426	35,475
Deferred revenue	19,931	10,000
Total current liabilities	180,040	190,305
Total liabilities	180,040	190,305
Stockholders’ equity:
Preferred stock, $0.001 par value; 50,000,000 shares authorized; and 0 shares issued and outstanding as of December 31, 2021 and March 31, 2021
Common stock, $0.001 par value; 250,000,000 shares authorized; 31,975,083 shares and 24,438,416 shares issued and outstanding as of December 31, 2021 and March 31, 2021, respectively	31,975	24,438
Additional paid in capital	10,962,495	4,584,214
Accumulated deficit	(7,595,933)	(3,983,626)
Total stockholders’ equity	3,398,537	625,026
Total Liabilities and Stockholders’ Equity	$ 3,578,577	$ 815,331

Balance Sheets (Unaudited) (Par

Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Dec. 31, 2021	Mar. 31, 2021
Statement of Financial Position [Abstract]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par or stated value per share	$ 0.001	$ 0.001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	31,975,083	24,438,416
Common stock, shares outstanding	31,975,083	24,438,416

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenue, net	$ 9,381		$ 21,256
Expenses:
Research and development	288,631	18,864	923,996	32,773
General and administrative expenses	931,108	229,999	2,676,535	544,014
Total operating expenses	1,219,739	248,863	3,600,531	576,787
Loss from operations	(1,210,358)	(248,863)	(3,579,275)	(576,787)
Other income (expense)
Change in fair value of derivative liability	(2,633)		4,128
Loss on debt extinguishment	(15,076)		(15,076)
Interest expense	(1,111)		(22,084)
Other expense	(18,820)		(33,032)
Net loss before provision for income taxes	(1,229,178)	(248,863)	(3,612,307)	(576,787)
Provision for income taxes
Net Loss	$ (1,229,178)	$ (248,863)	$ (3,612,307)	$ (576,787)
Net loss per common share:
Basic and diluted	$ (0.04)	$ (0.01)	$ (0.14)	$ (0.02)
Weighted average common shares outstanding:
Basic and diluted	29,455,337	23,561,493	26,461,277	23,344,000

Statements of Stockholders' Equ

Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Mar. 31, 2020		$ 22,810	$ 1,534,757	$ (1,620,044)	$ (62,477)
Beginning balance, share at Mar. 31, 2020		22,809,666
Issuance of common stock in connection with private placement		$ 478	478,272		478,750
Issuance of common stock in connection with private placement, shares		478,750
Net loss				(97,360)	(97,360)
Ending balance, value at Jun. 30, 2020		$ 23,288	2,013,029	(1,717,404)	318,913
Ending balance, share at Jun. 30, 2020		23,288,416
Beginning balance, value at Mar. 31, 2020		$ 22,810	1,534,757	(1,620,044)	(62,477)
Beginning balance, share at Mar. 31, 2020		22,809,666
Net loss					(576,787)
Ending balance, value at Dec. 31, 2020		$ 23,838	2,688,696	(2,196,831)	515,703
Ending balance, share at Dec. 31, 2020		23,838,416
Beginning balance, value at Jun. 30, 2020		$ 23,288	2,013,029	(1,717,404)	318,913
Beginning balance, share at Jun. 30, 2020		23,288,416
Issuance of common stock to consultants		$ 150	161,850		162,000
Issuance of common stock to consultants, shares		150,000
Net loss				(230,564)	(230,564)
Ending balance, value at Sep. 30, 2020		$ 23,438	2,174,879	(1,947,968)	250,349
Ending balance, share at Sep. 30, 2020		23,438,416
Issuance of common stock in connection with exercise of investor warrant		$ 400	399,600		400,000
Issuance of common stock in connection with exercise of investor warrant, shares		400,000
Stock-based compensation - employee and consultants option grants			164,217		164,217
Placement agent fee			(50,000)		(50,000)
Net loss				(248,863)	(248,863)
Ending balance, value at Dec. 31, 2020		$ 23,838	2,688,696	(2,196,831)	515,703
Ending balance, share at Dec. 31, 2020		23,838,416
Beginning balance, value at Mar. 31, 2021		$ 24,438	4,584,214	(3,983,626)	625,026
Beginning balance, share at Mar. 31, 2021		24,438,416
Stock-based compensation - employee and consultants option grants			316,896		316,896
Issuance of common stock in connection with exercise of common stock purchase warrants		$ 550	581,950		582,500
Issuance of common stock in connection with exercise of common stock purchase warrants , shares		550,000
Net loss				(1,204,591)	(1,204,591)
Ending balance, value at Jun. 30, 2021		$ 24,988	5,483,060	(5,188,217)	319,831
Ending balance, share at Jun. 30, 2021		24,988,416
Beginning balance, value at Mar. 31, 2021		$ 24,438	4,584,214	(3,983,626)	625,026
Beginning balance, share at Mar. 31, 2021		24,438,416
Net loss					(3,612,307)
Ending balance, value at Dec. 31, 2021		$ 31,975	10,962,495	(7,595,933)	3,398,537
Ending balance, share at Dec. 31, 2021		31,975,083
Beginning balance, value at Jun. 30, 2021		$ 24,988	5,483,060	(5,188,217)	319,831
Beginning balance, share at Jun. 30, 2021		24,988,416
Stock-based compensation - employee and consultants option grants			319,850		319,850
Issuance of common stock in connection with exercise of common stock purchase warrants		$ 100	99,900		100,000
Issuance of common stock in connection with exercise of common stock purchase warrants , shares		100,000
Issuance of common stock to customer		$ 10	9,990		10,000
Issuance of common stock to customer, shares		10,000
Net loss				(1,178,538)	(1,178,538)
Ending balance, value at Sep. 30, 2021		$ 25,098	5,912,800	(6,366,755)	(428,857)
Ending balance, share at Sep. 30, 2021		25,098,416
Stock-based compensation - employee and consultants option grants			321,571		321,571
Issuance of common stock in connection with exercise of common stock purchase warrants		$ 200	199,800		200,000
Issuance of common stock in connection with exercise of common stock purchase warrants , shares		200,000
Issuance of common stock and warrants, net of issuance cost		$ 6,667	4,518,334		4,525,001
Issuance of common stock and warrants net of issuance cost, shares		6,666,667
Issuance of common stock to customer		$ 10	9,990		10,000
Issuance of common stock to customer, shares		10,000
Net loss				(1,229,178)	(1,229,178)
Ending balance, value at Dec. 31, 2021		$ 31,975	$ 10,962,495	$ (7,595,933)	$ 3,398,537
Ending balance, share at Dec. 31, 2021		31,975,083

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash Flows from Operating Activities:
Net loss	$ (3,612,307)	$ (576,787)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation	978,317	326,217
Change in fair value of derivative liability	(4,128)
Loss on extinguishment of convertible note payable	15,076
Amortization of debt discount	22,084
Changes in operating assets and liabilities:
Accounts receivable	(6,325)
Prepaid expenses and other current assets	(52,338)
Accounts payable and accrued expenses	(7,147)	17,238
Payable to related party	(13,049)
Deferred revenue	9,931
Net cash flows used in operating activities	(2,669,886)	(233,332)
Cash Flows from Financing Activities:
Proceeds from issuance of common stock and warrants, net of placement agent fee	5,407,501	828,750
Proceeds from convertible note payable, net	126,250
Repayment of convertible note payable	(159,282)
Net cash flows provided by financing activities	5,374,469	828,750
Net change in cash	2,704,583	595,418
Cash at beginning of period	800,331	7,838
Cash at end of period	3,504,914	603,256
Supplemental disclosure of non-cash flow information
Common stock issued to customers for early adopter	20,000
Common stock issued to consultant in lieu of cash		$ 162,000

Business

Business	9 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Business	1. Business Our Corporate History On June 27, 2018 (the “Closing Date”), RocketFuel Blockchain Company (“RBC”) and B4MC Gold Mines, Inc., a Nevada Corporation (“B4MC” or the “Purchaser”), consummated the transactions contemplated by that certain Contribution Agreement (the “Contribution Agreement”) made and entered into as of June 27, 2018 by and among RBC, the Purchaser and Gert Funk, Joseph Page, PacificWave Partners Limited, PacificWave Partners UK Ltd. and Saxton Capital Ltd (collectively referred to herein as the “Sellers”, individually each a “Seller”). Pursuant to the Contribution Agreement the Sellers contributed, transferred, assigned and conveyed to B4MC all right, title and interest in and to one hundred percent ( 100% ) of the issued and outstanding Common Stock of RBC for an aggregate of 17,001,312 shares of Common Stock, par value $ 0.001 per share, of B4MC (the “Purchaser Common Stock”), (such transaction, the “Business Combination”). As a result of the Business Combination, RBC became a 100% wholly owned subsidiary of B4MC. In September 2018, B4MC changed its name to RocketFuel Blockchain, Inc. Prior to the Business Combination, B4MC was a “shell company,” as such term is defined in Rule 12b-2 under the Exchange Act. As a result of the Business Combination, we have ceased to be a “shell company.” The Business Combination was treated as a “reverse acquisition” of RBC for financial accounting purposes. RBC was considered the acquirer for accounting purposes, and the historical financial statements of B4MC before the Business Combination were replaced with the historical financial statements of RBC before the Business Combination in all future filings with the SEC. The Purchaser Common Stock issued to the Sellers in connection with the Business Combination have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), in reliance upon the exemption from registration provided by Section 4(a)(2), which exempts transactions by an issuer not involving any public offering, Regulation D and/or Regulation S promulgated by the SEC under that section. These shares may not be offered or sold in the United States absent registration or an applicable exemption from registration. In this report, references to RocketFuel, the “Company,” “we” and similar terms are to B4MC following the consummation of the reverse acquisition. The foregoing description of the Contribution Agreement does not purport to be complete. For further information, please refer to the copy of the Contribution Agreement included as Exhibit 2.1 to the Current Report on Form 8-K which was filed with the SEC on June 29, 2018. There are representations and warranties contained in the Contribution Agreement that were made by the parties to each other as of the date of execution. The assertions embodied in these representations and warranties were made solely for purposes of the Contribution Agreement and may be subject to important qualifications and limitations agreed to by the parties in connection with negotiating their terms. Moreover, some representations and warranties may not be accurate or complete as of any specified date because they are subject to a contractual standard of materiality that is different from certain standards generally applicable to shareholders or were used for the purpose of allocating risk between the parties rather than establishing matters as facts. For these reasons, investors should not rely on the representations and warranties in the Contribution Agreement as statements of factual information. Business We (or the “Company”) provide cryptocurrency and other check-out and payment systems that securely automate and simplify the way online payment and shipping information is received by merchants from their customers. Our “one click” checkout solution is modeled on the “buy now” button on leading eCommerce sites. Our check-out systems are designed to enhance customers’ data protection, enabling consumers to pay for goods and services using cryptocurrencies or by direct transfers from their bank accounts without exposing spending credentials such as credit card data. At the same time, our check-out systems are designed to increase the speed, security and ease of use for both customers and merchants and include a merchant portal that provides detailed transactions and metrics about payments received by the merchant. Our system also includes a customer portal where shoppers are able to track their payments, configure payment defaults and connect with various cryptocurrency exchanges and banks to facilitate payment to merchants. Merchants are able to integrate a unique pop-up user interface that allows customers to pay directly from their eCommerce checkout page with no need to redirect to another website or web page. Our corporate headquarters are located in San Francisco, California.

Interim Financial Statements an

Interim Financial Statements and Basis of Presentation	9 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Interim Financial Statements and Basis of Presentation	2. Interim Financial Statements and Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information pursuant to Rule 8-03 of Regulation S-X. Accordingly, these unaudited financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited financial statements include all adjustments (consisting only of normal recurring adjustments), which we consider necessary, for a fair presentation of those financial statements. The results of operations for the three and nine months ended December 31, 2021 and cash flows for the nine months ended December 31, 2021 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. These unaudited financial statements should be read in conjunction with our audited financial statements as of March 31, 2021 as filed with the Securities and Exchange Commission (the “SEC”) on July 22, 2021. ROCKETFUEL BLOCKCHAIN, INC. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2021 (UNAUDITED) The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments, which are evaluated on an ongoing basis, and that affect the amounts reported in our unaudited financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. Reclassifications Certain prior period amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations. Research and development expenses for the prior quarters of the current year, totaling $ 15,397 Earnings (Loss) Per Share The Company is authorized to issue 250,000,000 0.001 31,975,083 For the three and nine months ended December 31, 2021 and 2020, only basic earnings (losses) per share are presented. The effect of the Company’s outstanding convertible note payable, options and warrants, would have been anti-dilutive.

Summary of Significant Principl

Summary of Significant Principles	9 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Principles	3. Summary of Significant Principles Other than as discussed herein, our significant accounting policies are described in Note 3 to the audited financial statements as of March 31, 2021 which are included in our Annual Report on Form 10-K as filed with the SEC on July 22, 2021. Derivative Financial Instruments Derivative financial instruments, as defined in ASC 815, “Accounting for Derivative Financial Instruments and Hedging Activities”, consist of financial instruments or other contracts that contain a notional amount and one or more underlying variables (e.g. interest rate, security price or other variable), require no initial net investment and permit net settlement. Derivative financial instruments may be free-standing or embedded in other financial instruments. Further, derivative financial instruments are initially, and subsequently, measured at fair value and recorded as liabilities or, in rare instances, assets. We do not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, during the second quarter of fiscal 2022, we issued financial instruments including convertible promissory notes payable with embedded conversion features that do not afford equity classification. As required by ASC 815, these embedded conversion options are required to be carried as derivative liabilities, at fair value, in our financial statements (See Note 8). During the third quarter of fiscal 2022, these derivatives were satisfied. When derivative treatment is determined, we estimate the fair value of the bifurcated embedded conversion features using a Stock Path Monte Carlo Simulation model. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates (such as volatility, estimated life and risk-free rates of return) that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques are highly volatile and sensitive to changes in the trading market price of our common stock, which has a high-historical volatility. Income Taxes We are required to file federal and state income tax returns in the United States. The preparation of these tax returns requires us to interpret the applicable tax laws and regulations in effect in such jurisdictions, which could affect the amount of tax paid by us. In consultation with our tax advisors, we base our tax returns on interpretations that are believed to be reasonable under the circumstances. The tax returns, however, are subject to routine reviews by the various federal and state taxing authorities in the jurisdictions in which we file tax returns. As part of these reviews, a taxing authority may disagree with respect to the income tax positions taken by us (“uncertain tax positions”) and, therefore, may require us to pay additional taxes. As required under applicable accounting rules, we accrue an amount for our estimate of additional income tax liability, including interest and penalties, which we could incur as a result of the ultimate or effective resolution of the uncertain tax positions. We account for income taxes using the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences and carry-forwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. ROCKETFUEL BLOCKCHAIN, INC. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2021 (UNAUDITED)

Going Concern

Going Concern	9 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	4. Going Concern Our financial statements have been presented on the basis that we are a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. We incorporated our business on January 12, 2018, the date of our inception, and commenced commercial operations in March 2021. During the three and nine months ended December 31, 2021, we reported a net loss of $ 1,229,178 and $ 3,612,307 , respectively, which included as a component of general and administrative expenses in the statements of operations a non-cash stock-based compensation charge of $ 331,571 and $ 978,317 , respectively, and cash flows used in operating activities during the nine months ended December 31, 2021 of $ 2,669,886 . As a result, management believes that there is substantial doubt about our ability to continue as a going concern. We will require additional financing to continue to develop our product and execute on our business plan. However, there can be no assurances that we will be successful in raising the additional capital necessary to continue operations and execute on our business plan. During the six months ended September 30, 2021, we raised $ 682,500 through the exercise by certain investors of common stock purchase warrants. During the three months ended December 31, 2021, we completed a public offering of 6,666,667 shares of Common Stock and accompanying warrants to purchase 6,666,667 shares of Common Stock and raised $ 5,000,000 in gross proceeds. See Note 9 – Stockholders’ equity (deficit). We have used and plan to continue using the net proceeds of the private placement, warrant exercise and public offering to recruit key management and operational personnel, to retain software and blockchain developers and to develop our blockchain-based check-out solution. Management believes the funding from the private placement, the exercise of the common stock purchase warrants, the public offering and the growth strategy actions executed and planned for execution could contribute to our ability to mitigate any substantial doubt as to our ability to continue as a going concern.

New Accounting Pronouncements

New Accounting Pronouncements	9 Months Ended
	Dec. 31, 2021
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncements	5. New Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that may have an impact on our accounting and reporting. We believe that such recently issued accounting pronouncements and other authoritative guidance for which the effective date is in the future either will not have an impact on our accounting or reporting, or that such impact will not be material to our financial position, results of operations and cash flows when implemented.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	6. Related Party Transactions During the three and nine months ended December 31, 2021 and 2020, our chief financial officer was affiliated with legal counsel who provided us with general legal services (the “Affiliate”). We recorded legal fees paid to the Affiliate of $ 16,952 and $ 116,122 for the three and nine months ended December 31, 2021, respectively. We recorded legal fees paid to the Affiliate of $ 13,414 and $ 34,877 for the three and nine months ended December 31, 2020, respectively. As of December 31, 2021 and March 31, 2021, we had $ 22,426 and $ 35,475 , respectively, payable to the Affiliate. In the three and nine months ended December 31, 2021, we paid an affiliate of our executive chairman $ nil 3,000

Deferred Revenue

Deferred Revenue	9 Months Ended
	Dec. 31, 2021
Deferred Revenue
Deferred Revenue	7. Deferred Revenue We enter into certain contracts typically having initial one-year terms which define the scope of services to be provided. These contracts can include agreed-upon setup fees during the initial one-year term, which setup fees are recorded as deferred revenue and amortized ratably over the initial one-year term. During the three and nine months ended December 31, 2021, we recorded revenues of $ 9,381 21,256 ROCKETFUEL BLOCKCHAIN, INC. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2021 (UNAUDITED)

Convertible Note Payable

Convertible Note Payable	9 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Convertible Note Payable	8. Convertible Note Payable On August 4, 2021, we entered into a securities purchase agreement with a lender pursuant to which we sold a convertible note payable in the principal amount of $ 130,000 126,250 8 22 150 200 The convertible note gives us the right to prepay the note within the first 180 days from issuance at prepayment rates ranging from 110% to 125% of the then outstanding principal and interest balance. At any time during the period beginning 180 days from the origination date to the maturity date or date of default, the holder can convert all or any part of the outstanding balance into common stock at a conversion price per share equal to 65% of the lowest daily volume weighted average price of our common stock during the 10 trading days prior to the date of conversion. We evaluated the embedded conversion feature and concluded that it was required to be bifurcated and accounted for as a derivative liability due to the lack of explicit limit on the number of shares that may be required to be issued to settle the instrument. Accordingly, the fair value of the embedded conversion feature at inception was reflected as a derivative liability in the balance sheet, with a resulting discount applied to the note payable. At inception, the fair value of the conversion feature was deemed to be $ 120,151 as determined using a Stock Path Monte Carlo Simulation model. The key assumptions used in this valuation included: (1) dividend yield of 0 %, (2) expected volatility of 197.41 %, (3) risk-free interest rate of 0.07 %, (4) expected life of 1 year, and (5) the quoted market price of $ 1.01 for our common stock. On November 8, 2021, we repaid the convertible note in full. Using the same valuation method, the fair value of the embedded conversion feature at repayment was $ 116,023 2,633 4,128 15,076

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit)	9 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Stockholders’ Equity (Deficit)	9. Stockholders’ Equity (Deficit) On January 9, 2020, we sold 10,000 shares of our common stock to a private investor, resulting in cash proceeds of $ 10,000 . On February 13, 2020, we sold 11,250 shares of our common stock to a private investor, resulting in cash proceeds of $ 11,250 . On April 29, 2020, we entered into a subscription agreement with a private investor for the purchase of 478,750 shares of our common stock, at a purchase price of $ 1.00 per share, resulting in cash proceeds of $ 478,750 . All these transactions were part of a private placement of 500,000 shares of common stock. We paid a placement fee of $ 50,000 in connection with these transactions in the three months ended December 31, 2020. On August 24, 2020, we issued 150,000 162,000 1.08 On May 1, 2020, we issued a warrant to purchase 1,500,000 shares of common stock at $ 1.00 per share (the “First Warrant”). The warrant was to expire on April 30, 2021 . We also agreed that upon the full and timely exercise of the First Warrant, it would issue a second warrant for an additional 1,500,000 shares of common stock at a purchase price of $ 1.50 per share having a term of 12 months from the date of issue (the “Second Warrant”). The First Warrant was transferred to an affiliate of the original holder in November 2020. During the three-month period ended March 31, 2021, the warrant holder exercised warrants from the First Warrant to purchase 1,100,000 shares of our common stock of which (i) 1,000,000 shares of our common stock were issued in consideration of gross proceeds of $ 1,000,000 prior to March 31, 2021; and (ii) 100,000 shares of our common stock, for which we received notice of exercise on March 31, 2021, were issued in April 2021 in consideration of gross proceeds of $ 100,000 . Additionally, the warrant holder exercised the First Warrant for the remaining 400,000 shares of our common stock in April 2021 in consideration of gross proceeds of $ 400,000 . On April 26, 2021, we issued the Second Warrant to the holder. On August 6, 2021, we agreed to amend the terms of the Second Warrant to increase the number of shares purchasable to 2,250,000 and to reduce the exercise price to $ 1.00 per share. In the nine months ended December 31, 2021, the warrant holder exercised warrants from the Second Warrant to purchase 300,000 shares of our common stock at an exercise price of $ 1.00 per share. At December 31, 2021, there are 1,950,000 Second Warrants outstanding and exercisable. On October 11, 2021, we and Triton Funds, LP, a Delaware limited partnership (“Triton”), an unrelated third party, entered into an amendment to the Common Stock Purchase Agreement (the “CSPA”) dated February 25, 2021. Under the CSPA, Triton agreed to invest up to $ 1,000,000 in the Company through purchases of common stock during the commitment period (which runs through December 31, 2022). During the commitment period, the Company may, in its sole discretion, deliver purchase notices to Triton stating the dollar amount of shares which the Company intends to sell to Triton, not to exceed $ 500,000 per purchase notice. The amount to be funded under a purchase notice under the CSPA, as amended, is the number of shares of common stock to be purchased multiplied by the greater of (i) $ 1.00 (changed from $ 1.65 ) or (ii) eighty percent ( 80 %) of the lowest closing price of the common stock within fifteen business days prior to the closing date for the purchase. The closing date for each purchase is five business days following the date of the corresponding purchase notice. In connection with the amendment to the CSPA, the Company also amended the warrants issued to Triton. As amended the warrants are to purchase, in one or more instalments, 1,300,000 shares (increased from 800,000 under the CSPA) of the Company’s common stock (the “Warrants”) at an exercise price equal to the greater of (i) $ 1.00 per share (changed from $ 1.65 ) and (ii) eighty percent ( 80 %) of the average closing price of the common stock over the 90-calendar day period preceding the Warrant exercise date, subject to adjustments. The Warrants terminate on February 25, 2026. On May 5, 2021, Triton exercised 50,000 Warrants for an aggregate purchase price of $ 82,500 ($ 1.65 per share). After the amendment, 1,250,000 Warrants remain unexercised. ROCKETFUEL BLOCKCHAIN, INC. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2021 (UNAUDITED) On March 31, 2021, we entered into a contract with one customer having a one-year term from the date of execution that provided for (1) the payment of $ 10,000 in connection with the implementation of our blockchain technology and (2) the issuance of 10,000 shares of our common stock valued at $ 1.00 per share in consideration of being an early adopter of our blockchain technology. On August 4, 2021, we issued such 10,000 shares of our common stock to the customer. On October 6, 2021, we issued 10,000 From January 1, 2018 through December 31, 2021, we granted stock options under our 2018 Stock Incentive Plan, as amended, to issue up to an aggregate of 5,600,595 1.08 On February 15, 2021, we issued a warrant to purchase 265,982 1.00 All of these transactions were exempt from registration under the Securities Act of 1933 pursuant to Regulations D or S, or Rule 701, thereunder. On November 4, 2021, we completed a public offering (the “Offering”) of 6,666,667 0.001 6,666,667 0.75 0.75 five and one-half years On November 1, 2021, in connection with the Offering, we entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors. The Purchase Agreement sets forth the economic terms set forth above and contains customary representations and warranties of the Company, as well as certain indemnification obligations of the Company and ongoing covenants for the Company. In addition, under the Purchase Agreement, the Company has agreed not to issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of the Company’s (or its subsidiaries’) Common Stock or common stock equivalents for a period of 90 days from the closing of the Offering, other than certain exempt issuances. Additionally, the Company has also agreed for a period of two years following the closing date of the Offering not to (i) issue or agree to issue equity or debt securities convertible into, or exercisable or exchangeable for, Common Stock at a conversion price, exercise price or exchange price which floats with the trading price of our Common Stock or which may be adjusted after issuance upon the occurrence of certain events or (ii) enter into any agreement, including an equity line of credit, whereby the Company may issue securities at a future-determined price. This agreement does not apply to the offer, issuance or sale by the Company of Common Stock pursuant to an at-the-market offering facility the Company may enter with the placement agent of the Offering following expiration of the 90-day lock-up period. The net proceeds to the Company from the Offering, after deducting placement agent’s fees and other Offering expenses, and excluding the proceeds, if any, from the exercise of the Common Warrants, are approximately $ 4.37 In connection with the Offering, pursuant to an engagement letter (the “Engagement Letter”) dated as of July 9, 2021, as amended on September 20, 2021 and on October 28, 2021 between the Company and H.C. Wainwright & Co., LLC (“Wainwright”), the Company paid Wainwright (i) a total cash fee equal to 8.0 75,000 533,333 8.0 five years 125 0.9375 As of December 31, 2021, and March 31, 2021, we had 31,975,083 24,438,416 Warrants: The following is a summary of warrants for the nine months ended December 31, 2021: Summary of Warrants Warrants Weighted Average Outstanding at March 31, 2021 1,565,982 $ 1.00 1.65 Issued 9,950,000 0.75 1.00 Exercised (850,000 ) 1.00 1.65 Canceled - - Expired - - Outstanding and exercisable at December 31, 2021 10,665,982 $ 0.84 Weighted average remaining contractual term (years) 4.37 ROCKETFUEL BLOCKCHAIN, INC. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2021 (UNAUDITED)

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Dec. 31, 2021
Compensation Related Costs [Abstract]
Stock-Based Compensation	10. Stock-Based Compensation Stock Option Plan On August 8, 2018, the Board and stockholders holding a majority of our voting power approved the RocketFuel Blockchain, Inc., 2018 Plan, which plan enables us to make awards that qualify as performance-based compensation. Under the terms of the 2018 Plan, the options will (i) be incentive stock options, (ii) have an exercise price equal to the fair market value per share of our common stock on the date of grant as determined by an independent valuation by a qualified appraiser, (iii) have a term of 10 2,000,000 4,000,000 6,000,000 399,405 502,230 Service-Based Stock Option Grants From August 8, 2018 through December 31, 2021, we granted service-based options to employees and consultants, pursuant to the 2018 Plan, exercisable into a total of 5,000,595 Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Service-Based Options Option exercise price per share $ 1.00 2.75 Grant date fair market value per share $ 1.00 2.75 Expected term of option in years 6.25 Expected volatility 40.3 220.5 % Expected dividend rate 0.00 % Risk free interest rate 0.42 2.83 % During the three months ended December 31, 2021, we granted no service-based options pursuant to the 2018 Plan. During the nine months ended December 31, 2021, we granted service-based options pursuant to the 2018 Plan to (i) one employee exercisable into 2,825 1.00 2.75 100,000 1.08 Service-Based Options Option exercise price per share $ 1.00 2.75 Grant date fair market value per share $ 1.00 2.75 Expected term of option in years 6.25 Expected volatility 218.1 220.5 % Expected dividend rate 0.00 % Risk free interest rate 0.71 1.02 % ROCKETFUEL BLOCKCHAIN, INC. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2021 (UNAUDITED) Activity under the 2018 Plan for all service-based stock options for the nine months ended December 31, 2021 are as follows: Schedule of Stock Option Activity Options Outstanding Weighted- Average Exercise Price per Share Weighted- Average Remaining Contractual Term in Years Aggregate Intrinsic Value Options outstanding at April 1, 2021: 4,897,770 $ 1.08 9.63 $ 1,175,417 Granted 102,825 1.10 9.59 - Exercised - Cancelled or forfeited - Options outstanding as of December 31, 2021 5,000,595 $ 1.08 7.73 $ nil Options exercisable as of December 31, 2021 1,830,448 $ 1.08 7.73 $ nil Options vested or expected to vest as of December 31, 2021 1,830,448 $ 1.08 7.73 $ nil The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the closing price of the common stock on December 31, 2021 of $ 0.24 and the exercise price of each in-the-money option) that would have been received by the option holders had all option holders exercised their options on December 31, 2021. There were no service-based stock options exercised under the 2018 Plan for the three and nine months ended December 31, 2021 and 2020. For the three and nine months ended December 31, 2021, we recorded stock-based compensation expense for service-based stock options pursuant to the 2018 Plan in the amount of $ 296,167 882,105 164,217 164,217 3,326,852 Performance-Based Stock Option Grants We also granted performance-based options pursuant to the 2018 Plan to Rohan Hall, our chief technology officer, which are exercisable into 600,000 The Board of Directors also entered into a resolution whereby 75,000 525,000 In determining the fair value of the performance-based options granted to Mr. Hall on September 14, 2020 and earned effective February 1, 2021, we utilized the Black-Scholes pricing model utilizing the following assumptions: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Performance -Based Options Option exercise price per share $ 1.08 Grant date fair market value per share $ 1.08 Expected term of option in years 6.25 Expected volatility 240.1 % Expected dividend rate 0.00 % Risk free interest rate 0.54 % ROCKETFUEL BLOCKCHAIN, INC. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2021 (UNAUDITED) Activity under the 2018 Plan for all performance-based stock options for the nine months ended December 31, 2021 is as follows: Schedule of Stock Option Activity Options Outstanding Weighted- Average Exercise Price per Share Weighted- Average Remaining Contractual Term in Years Aggregate Intrinsic Value Balance at April 1, 2021 600,000 $ 1.08 9.83 $ 144,000 Granted - Exercised - Cancelled or forfeited - Options outstanding as of December 31, 2021 600,000 $ 1.08 8.71 $ nil Options exercisable as of December 31, 2021 184,380 $ 1.08 8.71 $ nil Options vested or expected to vest as of December 31, 2021 184,380 $ 1.08 8.71 $ nil The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the closing price of the common stock on December 31, 2021 of $ 0.24 and the exercise price of each in-the-money option) that would have been received by the option holders had all option holders exercised their options on December 31, 2021. There were no performance-based stock options exercised under the 2018 Plan for the three and nine months ended December 31, 2021 and 2020. For the three and nine months ended December 31, 2021, we recorded performance-based compensation expense for performance-based stock options pursuant to the 2018 Plan in the amount of $ 25,404 and $ 76,212 , respectively. For the three and nine months ended December 31, 2020, we recorded no performance-based compensation expense for performance-based stock options pursuant to the 2018 Plan. As of December 31, 2021, we had $ 321,763 of unrecognized stock-based compensation cost related to performance-based stock options.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies Legal Proceedings On October 8, 2020, the Company filed a lawsuit in the U.S. District Court for the Central District of California against Joseph Page, our former director and chief technology officer. On January 13, 2021, the case was transferred to the U.S. District Court for the District of Nevada, Las Vegas Division. The causes of action include securities fraud under Federal and California law; fraud, breach of fiduciary duty, negligent misrepresentation and unjust enrichment under California law; and violation of California Business and Professions Code §17200 et seq. We are seeking injunctive and declaratory relief as well as damages of at least $ 5.1 On May 29, 2019, Mr. Page resigned from the Company’s board. After his resignation, the Company retained independent patent counsel to review its patent applications. In connection with this review, the Company discovered certain deficiencies in some of the applications and in their assignments to the Company. determined that all of the applications had been abandoned. Based on this review, the Company decided to refile three of its applications with the U.S. Patent and Trademark Office, which the Company did in May 2020. It is the Company’s belief that the three newly filed patent applications cover and/or disclose the same subject matter as the Company disclosed in the five original patent applications. In this case, the Company’s rights may be subject to any intervening patent applications made after the dates of the original applications. In the lawsuit, the Company is alleging that Mr. Page was aware of the abandonments when he assigned the patents to RBC, a private corporation that he controlled, and that he failed to disclose to the Company the abandonments when the Company acquired RBC in exchange for shares of the Company’s Common Stock. Mr. Page has filed an answer denying the Company’s clams and has asserted cross- and counterclaims against the Company and several of the Company’s shareholders alleging breach of contract and fraud. In September 2021, Mr. Page voluntarily dismissed all of the counterclaims against the shareholders. The Company intends to vigorously contest these allegations. On March 2, 2021, the Company filed a lawsuit in the U.S. District Court for the Southern District of New York against Ellenhoff Grossman & Schole LLP (“EGS”) for negligence and legal malpractice, breach of contract and breach of fiduciary duty. EGS had represented RBC prior to the Business Combination and represented us after the closing of the Business Combination through August 2019. In the litigation against Mr. Page, he has alleged that he provided information to an EGS partner that the patent applications had been abandoned and that EGS failed to inform RBC and us of that fact. We are seeking damages and the return of legal fees previously paid. At the date of this report, the Company is unable to estimate the probability success or dollar amount of rulings in either of these cases, and as a result, has not accrued any potential benefit to the Company’s balance sheet. Attorney fees related to these proceedings are expensed as incurred.

Subsequent Events

Subsequent Events	9 Months Ended
	Dec. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	12. Subsequent Events In order to re-incentivize and retain its employees, on January 11, 2022, the Company’s board of directors approved a one-time stock option repricing for all stock options issued and outstanding under our 2018 Stock Incentive Plan. The effect of the repricing will be a charge to operations over the remaining terms of the options and will begin to be recorded in the quarter ending March 31, 2022. The charge is noncash, is equity-neutral and in the opinion of management will have no material impact on the Company’s operating activities.

Summary of Significant Princi_2

Summary of Significant Principles (Policies)	9 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Derivative financial instruments, as defined in ASC 815, “Accounting for Derivative Financial Instruments and Hedging Activities”, consist of financial instruments or other contracts that contain a notional amount and one or more underlying variables (e.g. interest rate, security price or other variable), require no initial net investment and permit net settlement. Derivative financial instruments may be free-standing or embedded in other financial instruments. Further, derivative financial instruments are initially, and subsequently, measured at fair value and recorded as liabilities or, in rare instances, assets. We do not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, during the second quarter of fiscal 2022, we issued financial instruments including convertible promissory notes payable with embedded conversion features that do not afford equity classification. As required by ASC 815, these embedded conversion options are required to be carried as derivative liabilities, at fair value, in our financial statements (See Note 8). During the third quarter of fiscal 2022, these derivatives were satisfied. When derivative treatment is determined, we estimate the fair value of the bifurcated embedded conversion features using a Stock Path Monte Carlo Simulation model. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates (such as volatility, estimated life and risk-free rates of return) that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques are highly volatile and sensitive to changes in the trading market price of our common stock, which has a high-historical volatility.
Income Taxes	Income Taxes We are required to file federal and state income tax returns in the United States. The preparation of these tax returns requires us to interpret the applicable tax laws and regulations in effect in such jurisdictions, which could affect the amount of tax paid by us. In consultation with our tax advisors, we base our tax returns on interpretations that are believed to be reasonable under the circumstances. The tax returns, however, are subject to routine reviews by the various federal and state taxing authorities in the jurisdictions in which we file tax returns. As part of these reviews, a taxing authority may disagree with respect to the income tax positions taken by us (“uncertain tax positions”) and, therefore, may require us to pay additional taxes. As required under applicable accounting rules, we accrue an amount for our estimate of additional income tax liability, including interest and penalties, which we could incur as a result of the ultimate or effective resolution of the uncertain tax positions. We account for income taxes using the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributed to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences and carry-forwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. ROCKETFUEL BLOCKCHAIN, INC. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2021 (UNAUDITED)

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit) (Tables)	9 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Summary of Warrants	The following is a summary of warrants for the nine months ended December 31, 2021: Summary of Warrants Warrants Weighted Average Outstanding at March 31, 2021 1,565,982 $ 1.00 1.65 Issued 9,950,000 0.75 1.00 Exercised (850,000 ) 1.00 1.65 Canceled - - Expired - - Outstanding and exercisable at December 31, 2021 10,665,982 $ 0.84 Weighted average remaining contractual term (years) 4.37

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Dec. 31, 2021
Service Based Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Service-Based Options Option exercise price per share $ 1.00 2.75 Grant date fair market value per share $ 1.00 2.75 Expected term of option in years 6.25 Expected volatility 40.3 220.5 % Expected dividend rate 0.00 % Risk free interest rate 0.42 2.83 % Service-Based Options Option exercise price per share $ 1.00 2.75 Grant date fair market value per share $ 1.00 2.75 Expected term of option in years 6.25 Expected volatility 218.1 220.5 % Expected dividend rate 0.00 % Risk free interest rate 0.71 1.02 %
Schedule of Stock Option Activity	Activity under the 2018 Plan for all service-based stock options for the nine months ended December 31, 2021 are as follows: Schedule of Stock Option Activity Options Outstanding Weighted- Average Exercise Price per Share Weighted- Average Remaining Contractual Term in Years Aggregate Intrinsic Value Options outstanding at April 1, 2021: 4,897,770 $ 1.08 9.63 $ 1,175,417 Granted 102,825 1.10 9.59 - Exercised - Cancelled or forfeited - Options outstanding as of December 31, 2021 5,000,595 $ 1.08 7.73 $ nil Options exercisable as of December 31, 2021 1,830,448 $ 1.08 7.73 $ nil Options vested or expected to vest as of December 31, 2021 1,830,448 $ 1.08 7.73 $ nil
Performance Based Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	In determining the fair value of the performance-based options granted to Mr. Hall on September 14, 2020 and earned effective February 1, 2021, we utilized the Black-Scholes pricing model utilizing the following assumptions: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Performance -Based Options Option exercise price per share $ 1.08 Grant date fair market value per share $ 1.08 Expected term of option in years 6.25 Expected volatility 240.1 % Expected dividend rate 0.00 % Risk free interest rate 0.54 %
Performance Based Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Stock Option Activity	Activity under the 2018 Plan for all performance-based stock options for the nine months ended December 31, 2021 is as follows: Schedule of Stock Option Activity Options Outstanding Weighted- Average Exercise Price per Share Weighted- Average Remaining Contractual Term in Years Aggregate Intrinsic Value Balance at April 1, 2021 600,000 $ 1.08 9.83 $ 144,000 Granted - Exercised - Cancelled or forfeited - Options outstanding as of December 31, 2021 600,000 $ 1.08 8.71 $ nil Options exercisable as of December 31, 2021 184,380 $ 1.08 8.71 $ nil Options vested or expected to vest as of December 31, 2021 184,380 $ 1.08 8.71 $ nil

Business (Details Narrative)

Business (Details Narrative) - $ / shares	Jun. 27, 2018	Dec. 31, 2021	Mar. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common Stock, Shares, Issued		31,975,083	24,438,416
Common Stock, Par or Stated Value Per Share		$ 0.001	$ 0.001
Contribution Agreement [Member] | B4MC Gold Mines Inc [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum	100.00%
Common Stock, Shares, Issued	17,001,312
Common Stock, Par or Stated Value Per Share	$ 0.001
Equity Method Investment, Ownership Percentage	100.00%

Interim Financial Statements _2

Interim Financial Statements and Basis of Presentation (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Mar. 31, 2021
Research and development expense	$ 288,631	$ 18,864	$ 923,996	$ 32,773
Common stock, shares authorized	250,000,000		250,000,000		250,000,000
Common stock, par or stated value per share	$ 0.001		$ 0.001		$ 0.001
Common stock, shares issued	31,975,083		31,975,083		24,438,416
Common stock, shares outstanding	31,975,083		31,975,083		24,438,416
General and Administrative Expense [Member]
Research and development expense			$ 15,397

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Nov. 04, 2021	Oct. 06, 2021	Apr. 29, 2020	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net Income (Loss) Attributable to Parent				$ 1,229,178	$ 1,178,538	$ 1,204,591	$ 248,863	$ 230,564	$ 97,360		$ 3,612,307	$ 576,787
Share-based Payment Arrangement, Noncash Expense				$ 331,571							978,317
Net Cash Provided by (Used in) Operating Activities											$ 2,669,886	$ 233,332
Sale of Stock, Number of Shares Issued in Transaction	6,666,667	10,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	6,666,667			6,666,667							6,666,667
Subscription Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of Stock, Number of Shares Issued in Transaction			478,750
Private Placement [Member] | Subscription Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from Issuance of Private Placement				$ 5,000,000						$ 682,500
Sale of Stock, Number of Shares Issued in Transaction			500,000
IPO [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of Stock, Number of Shares Issued in Transaction				6,666,667

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Mar. 31, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Legal Fees	$ 16,952	$ 13,414		$ 116,122	$ 34,877
Due to Related Parties, Current	22,426			22,426		$ 35,475
Affililate [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Due to Related Parties, Current	22,426			$ 22,426		$ 35,475
Executive Chairman [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Payment to affililate party	$ 0		$ 3,000

Deferred Revenue (Details Narra

Deferred Revenue (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Deferred Revenue
Revenues	$ 9,381		$ 21,256

Convertible Note Payable (Detai

Convertible Note Payable (Details Narrative) - USD ($)	Nov. 08, 2021	Aug. 04, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Short-term Debt [Line Items]
Fair value of derivative liability			$ 2,633		$ 4,128
Loss on debt extinguishment			$ 15,076		$ 15,076
Monte Carlo Simulation Model [Member]
Short-term Debt [Line Items]
Debt Instrument, Convertible, Conversion Price		$ 1.01
Monte Carlo Simulation Model [Member] | Measurement Input, Expected Dividend Rate [Member]
Short-term Debt [Line Items]
Debt Instrument, Measurement Input		0
Monte Carlo Simulation Model [Member] | Measurement Input, Option Volatility [Member]
Short-term Debt [Line Items]
Debt Instrument, Measurement Input		197.41
Monte Carlo Simulation Model [Member] | Measurement Input, Risk Free Interest Rate [Member]
Short-term Debt [Line Items]
Debt Instrument, Measurement Input		0.0007
Monte Carlo Simulation Model [Member] | Measurement Input, Expected Term [Member]
Short-term Debt [Line Items]
Debt Instrument, Term		1 year
Convertible Promissory Note [Member]
Short-term Debt [Line Items]
Convertiable notes payable		$ 130,000
Cash proceeds		$ 126,250
Interest rate percentage		8.00%
Increase in interest on interest percentage		22.00%
Debt conversion description		The convertible note gives us the right to prepay the note within the first 180 days from issuance at prepayment rates ranging from 110% to 125% of the then outstanding principal and interest balance. At any time during the period beginning 180 days from the origination date to the maturity date or date of default, the holder can convert all or any part of the outstanding balance into common stock at a conversion price per share equal to 65% of the lowest daily volume weighted average price of our common stock during the 10 trading days prior to the date of conversion.
Debt Instrument, Convertible, Beneficial Conversion Feature		$ 120,151
Repayments of debt	$ 116,023
Convertible Promissory Note [Member] | Minimum [Member]
Short-term Debt [Line Items]
Increase in interest on interest percentage		150.00%
Convertible Promissory Note [Member] | Maximum [Member]
Short-term Debt [Line Items]
Increase in interest on interest percentage		200.00%

Summary of Warrants (Details)

Summary of Warrants (Details)	9 Months Ended
	Dec. 31, 2021$ / sharesshares
Warrants Outstanding | shares	1,565,982
Warrants Issued | shares	9,950,000
Warrants Exercised | shares	(850,000)
Warrants Expired | shares
Weighted Average Exercise Price, Canceled
Warrants Expired | shares
Weighted Average Exercise Price, Expired
Warrants Outstanding and exercisable | shares	10,665,982
Weighted Average Exercise Price, Outstanding and exercisable	$ 0.84
Weighted average remaining contractual term (years)	4 years 4 months 13 days
Minimum [Member]
Weighted Average Exercise Price, Outstanding	$ 1
Weighted Average Exercise Price, Issued	0.75
Weighted Average Exercise Price, Exercised	1
Maximum [Member]
Weighted Average Exercise Price, Outstanding	1.65
Weighted Average Exercise Price, Issued	1
Weighted Average Exercise Price, Exercised	$ 1.65

Stockholders_ Equity (Deficit_2

Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)	Nov. 04, 2021	Oct. 11, 2021	Oct. 06, 2021	Aug. 04, 2021	May 05, 2021	Aug. 24, 2020	Apr. 29, 2020	Feb. 13, 2020	Jan. 09, 2020	Apr. 30, 2021	Mar. 31, 2021	Dec. 31, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Oct. 28, 2021	Sep. 30, 2021	Aug. 06, 2021	Feb. 15, 2021	May 01, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Public offering shares	6,666,667		10,000
Fair value of stocks issued in offering, per share	$ 0.001
Common stock value issued for service															$ 162,000
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right																							1,500,000
Class of warrants, exercise price	$ 0.75																						$ 1
Warrants and Rights Outstanding, Maturity Date																							Apr. 30, 2021
Warrants to purchase	6,666,667											6,666,667				6,666,667		6,666,667
Proceeds from Issuance of Common Stock																$ 5,407,501	$ 828,750
Class of warrants exercisable, description	five and one-half years
Aggregate number of common stock																			8.00%
Common stock, shares issued											24,438,416	31,975,083	24,438,416			31,975,083		31,975,083
Common stock, shares outstanding											24,438,416	31,975,083	24,438,416			31,975,083		31,975,083
Blockchain Technology [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Public offering shares				10,000							10,000
Fair value of stocks issued in offering, per share											$ 1		$ 1
Blockchain Technology [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of Stock, Consideration Received on Transaction											$ 10,000
Triton Funds LP [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from Warrant Exercises					$ 82,500
Class of warrant or right number of warrants exercise					50,000
Class of warrant or right aggregate purchase price of warrants or rights					$ 1.65
Class of warrant or right number of warrants remain unexercised					1,250,000
Second Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of warrants, exercise price												$ 1				$ 1		$ 1
Warrants to purchase												300,000				300,000		300,000
Warrant to purchase of common shares												1,950,000				1,950,000		1,950,000
Consultant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock shares issued for service						150,000
Common stock value issued for service						$ 162,000
Price per share of common stock						$ 1.08
Warrant Holder [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Public offering shares													1,000,000
Sale of Stock, Consideration Received on Transaction													$ 1,000,000
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right											1,100,000		1,100,000
Stock issued during period shares warrants exercised													100,000
Stock issued during period value warrants exercised													$ 100,000
Warrants to purchase										400,000
Proceeds from Warrant Exercises										$ 400,000
Employees Directors And Consultants [Member] | 2018 Stock Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of common stock shares available for grant												5,600,595				5,600,595		5,600,595
Exercise Price per share																		$ 1.08
Chief Executive Officer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of warrants, exercise price																						$ 1
Warrant to purchase of common shares																						265,982
IPO [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Public offering shares												6,666,667
Class of warrants, exercise price	$ 0.75
Proceeds from Issuance Initial Public Offering	$ 4,370,000
Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Public offering shares							478,750
Sale of Stock, Consideration Received on Transaction							$ 478,750
Fair value of stocks issued in offering, per share							$ 1
Subscription Agreement [Member] | Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Public offering shares							500,000
Private placement fee amount paid														$ 50,000
Common Stock Purchase Agreement [Member] | Triton Funds LP [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from Issuance of Common Stock		$ 1,000,000
Sale of Stock, Consideration Received Per Transaction																$ 500,000
Engagement Letter [Member] | H C Wainwright And Co L L C [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Price per share of common stock																			$ 0.9375
Warrants and rights outstanding, term																			5 years
Warrants to purchase																			533,333
Percentage of cash fee from sale of the securities																			8.00%
Non accountable expense allowance																			$ 75,000
Percentage of warrants exercise price																			125.00%
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock shares issued for service															150,000
Common stock value issued for service															$ 150
Second Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right																					2,250,000		1,500,000
Class of warrants, exercise price																					$ 1		$ 1.50
Warrants and rights outstanding, term																							12 months
Triton Warrant [Member] | Common Stock Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fair value of stocks issued in offering, per share												$ 1				$ 1		1		$ 1.65
Triton Warrant [Member] | Stock Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fair value of stocks issued in offering, per share												$ 1				$ 1		$ 1		$ 1.65
Warrants to purchase												1,300,000				1,300,000		1,300,000		800,000
Closing price percentage																80.00%
Private Investor [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Public offering shares								11,250	10,000
Sale of Stock, Consideration Received on Transaction								$ 11,250	$ 10,000

Schedule of Share-based Payment

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)	9 Months Ended
	Dec. 31, 2021$ / shares
Service Based Stock Option [Member] | Employees And Consultants [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Expected term of option in years	6 years 3 months
Expected dividend rate	0.00%
Service Based Stock Option [Member] | Employees [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Expected term of option in years	6 years 3 months
Expected dividend rate	0.00%
Performance Based Options [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Option exercise price per share	$ 1.08
Grant date fair market value per share	$ 1.08
Expected term of option in years	6 years 3 months
Expected volatility	240.10%
Expected dividend rate	0.00%
Risk free interest rate	0.54%
Minimum [Member] | Service Based Stock Option [Member] | Employees And Consultants [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Option exercise price per share	$ 1
Grant date fair market value per share	$ 1
Expected volatility	40.30%
Risk free interest rate	0.42%
Minimum [Member] | Service Based Stock Option [Member] | Employees [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Option exercise price per share	$ 1
Grant date fair market value per share	$ 1
Expected volatility	218.10%
Risk free interest rate	0.71%
Maximum [Member] | Service Based Stock Option [Member] | Employees And Consultants [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Option exercise price per share	$ 2.75
Grant date fair market value per share	$ 2.75
Expected volatility	220.50%
Risk free interest rate	2.83%
Maximum [Member] | Service Based Stock Option [Member] | Employees [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Option exercise price per share	$ 2.75
Grant date fair market value per share	$ 2.75
Expected volatility	220.50%
Risk free interest rate	1.02%

Schedule of Stock Option Activi

Schedule of Stock Option Activity (Details)	9 Months Ended
	Dec. 31, 2021USD ($)$ / sharesshares
Service Based Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option Outstanding, Number, Beginning Balance	4,897,770
Weighted Average Exercise Price Per Share, Number Beginning Balance | $ / shares	$ 1.08
Weighted Average Remaining Contractual Term in Years, Beginning Balance	9 years 7 months 17 days
Aggregate Intrinsic Value, Beginning Balance | $	$ 1,175,417
Option Outstanding, Granted	102,825
Weighted Average Exercise Price Per Share, Granted | $ / shares	$ 1.10
Weighted Average Remaining Contractual Term in Years, Granted	9 years 7 months 2 days
Aggregate Intrinsic Value, Granted | $ / shares
Option Outstanding, Exercised
Option Outstanding, Cancelled or Forfeited
Option Outstanding, Number, Ending Balance	5,000,595
Weighted Average Exercise Price Per Share, Number Ending Balance | $ / shares	$ 1.08
Weighted Average Remaining Contractual Term in Years, Ending Balance	7 years 8 months 23 days
Aggregate Intrinsic Value, Ending Balance | $
Option Outstanding, Options Exercisable Ending Balance	1,830,448
Weighted Average Exercise Price Per Share, Options Exercisable Ending Balance | $ / shares	$ 1.08
Weighted Average Remaining Contractual Term in Years, Options Exercisable Ending Balance	7 years 8 months 23 days
Aggregate Intrinsic Value, Options Exercisable Ending Balance | $
Option Outstanding, Vested or Expected to Vest, Ending Balance	1,830,448
Weighted Average Exercise Price Per Share, Vested or Expected to Vest Ending Balance | $ / shares	$ 1.08
Weighted Average Remaining Contractual Term in Years, Options	7 years 8 months 23 days
Aggregate Intrinsic Value Options Options Vested or Expected to Vest Ending Balance | $
Performance Based Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option Outstanding, Number, Beginning Balance	600,000
Weighted Average Exercise Price Per Share, Number Beginning Balance | $ / shares	$ 1.08
Weighted Average Remaining Contractual Term in Years, Beginning Balance	9 years 9 months 29 days
Aggregate Intrinsic Value, Beginning Balance | $	$ 144,000
Option Outstanding, Granted
Option Outstanding, Exercised
Option Outstanding, Cancelled or Forfeited
Option Outstanding, Number, Ending Balance	600,000
Weighted Average Exercise Price Per Share, Number Ending Balance | $ / shares	$ 1.08
Weighted Average Remaining Contractual Term in Years, Ending Balance	8 years 8 months 15 days
Aggregate Intrinsic Value, Ending Balance | $
Option Outstanding, Options Exercisable Ending Balance	184,380
Weighted Average Exercise Price Per Share, Options Exercisable Ending Balance | $ / shares	$ 1.08
Weighted Average Remaining Contractual Term in Years, Options Exercisable Ending Balance	8 years 8 months 15 days
Aggregate Intrinsic Value, Options Exercisable Ending Balance | $
Option Outstanding, Vested or Expected to Vest, Ending Balance	184,380
Weighted Average Exercise Price Per Share, Vested or Expected to Vest Ending Balance | $ / shares	$ 1.08
Weighted Average Remaining Contractual Term in Years, Options	8 years 8 months 15 days
Aggregate Intrinsic Value Options Options Vested or Expected to Vest Ending Balance | $

Stock-Based Compensation (Detai

Stock-Based Compensation (Details Narrative) - USD ($)	Mar. 18, 2021	Aug. 08, 2018	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 30, 2021	Dec. 31, 2020	Mar. 31, 2021	Sep. 15, 2020
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Stock-based compensation			$ 331,571		$ 978,317
Service Based Stock Option [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Stock option, term					7 years 8 months 23 days
Number of stock option exercisable			1,830,448		1,830,448
Exercise Price per share					$ 1.10
Unrecognized stock-based compensation			$ 3,326,852		$ 3,326,852
Performance Based Options [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Stock option, term					8 years 8 months 15 days
Number of stock option exercisable			184,380		184,380
Share-based compensation arrangement by share-based payment award, award vesting rights	The Board of Directors also entered into a resolution whereby 75,000 shares of our common stock underlying the performance-based options would vest immediately and 525,000 shares of our common stock underlying the performance-based option would vest ratably over a 48-month period with the first vesting date being February 1, 2021.
Share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number	75,000
Closing price of common stock			$ 0.24		$ 0.24
Performance Based Options [Member] | February 1, 2021 [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number	525,000
2018 Plan [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Stock option, term		10 years
Common stock, capital shares reserved for future issuance		2,000,000
Shares available for grant	6,000,000		399,405		399,405			502,230	4,000,000
2018 Plan [Member] | Service Based Stock Option [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Stock-based compensation			$ 296,167	$ 164,217		$ 882,105	$ 164,217
2018 Plan [Member] | Performance Based Options [Member] | Rohan Hall [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Number of stock option exercisable			600,000		600,000
2018 [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Exercise Price per share					$ 0.24
2018 [Member] | Service Based Stock Options To Employees And Consultants [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Number of stock option exercisable			5,000,595		5,000,595
2018 [Member] | Service Based Stock Options To Employees [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Number of stock option exercisable			2,825		2,825
2018 [Member] | Service Based Stock Options To Employees [Member] | One Consultant [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Number of stock option exercisable			100,000		100,000
Exercise Price per share					$ 1.08
2018 [Member] | Service Based Stock Options To Employees [Member] | Minimum [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Exercise Price per share					1
2018 [Member] | Service Based Stock Options To Employees [Member] | Maximum [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Exercise Price per share					$ 2.75
2018 [Member] | Performance Based Options [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Stock-based compensation			$ 25,404			$ 76,212
Unrecognized stock-based compensation			$ 321,763		$ 321,763

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) $ in Millions	Oct. 08, 2020USD ($)
Commitments and Contingencies Disclosure [Abstract]
Damages sought value	$ 5.1